The Office of the United States Trade Representative (“USTR”) announced that it is extending certain product-specific exclusions related to the treatment of COVID-19 from the Section 301 tariffs on imports from China until March 31, 2021. On March 25, 2020, the USTR announced that it was seeking comments on the possible exemption of medical goods







